CJC-1295 W/O DAC 5mg + Ipamorelin 5mgCJC-1295 W/O DAC 5mg + Ipamorelin 5mg

CJC-1295 No DAC 5mg + Ipamorelin 5mg (10mg Total Peptide Blend) – Research Grade

What Is the CJC-1295 No DAC and Ipamorelin Peptide Blend?

The CJC-1295 No DAC and Ipamorelin peptide blend is a research-grade combination of two well-documented synthetic peptides commonly studied in laboratory settings for their role in growth hormone–related signalling pathways.

CJC-1295 No DAC, also known as Modified GRF (1–29), is a synthetic analogue of growth hormone–releasing hormone (GHRH). Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. When examined together in research models, these peptides are frequently studied for their complementary receptor activity.

This product is supplied strictly for scientific research, laboratory analysis, and educational purposes only. It is not intended for human or animal use.

Chemical Composition and Molecular Information

Maintaining chemical accuracy is critical for peptide research. The molecular specifications below are consistent with established biochemical references.

Product Details:

Name: CJC 1295 without DAC 5mg

Catalogue Number: GP-CJC1295WD-5

Molecular Formula: C152H252N44O42

Molecular Weight: 3368.7 g/mol

Purity: 98%

CAS Number: 863288-34-0

Form: Lyophilised Powder

Name: Ipamorelin 5mg

Catalogue Number: GP-IPAMO-5

Molecular Formula: C₃₈H₄₉N₉O₅

Molecular Weight: 711.9 g/mol

Purity: ≥98%

Peptide Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

Form: Lyophilised powder

The combined vial contains 5mg of CJC-1295 No DAC and 5mg of Ipamorelin, resulting in a total peptide content of 10mg.